These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 4381452)

  • 1. Effect of prostaglandin E1 on blood pressure and heart rate in the dog. Prostaglandin and related factors 48.
    Carlson LA; Orö L
    Acta Physiol Scand; 1966 May; 67(1):89-99. PubMed ID: 4381452
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of prostaglandins E1 and E2 on the smooth muscle of the dog spleen and on its responses to catecholamines, angiotensin and nerve stimulation.
    Davies BN; Withrington PG
    Br J Pharmacol Chemother; 1968 Jan; 32(1):136-44. PubMed ID: 4295820
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of actions of catecholamines by a derivative of hemicholinium.
    Wong S; Long JP
    J Pharmacol Exp Ther; 1967 Jun; 156(3):469-82. PubMed ID: 4381801
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the sympathetic nervous system in the cardiovascular effects of systemically administered gamma-aminobutyric acid.
    Vemulapalli S; Barletta M
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):46-58. PubMed ID: 6144293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular stimulant responses following intravenous administration of MJ 9465-2 (2-amino-4-(4-chlorophenyl)-2-imidazoline-HBr) in the dog: mechanisms of action.
    Deitchman D; Gomoll AW; Snyder RW; McKinney GR
    Eur J Pharmacol; 1974 May; 26(2):366-74. PubMed ID: 4152804
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interactions between propranolol and some drugs on the pressor effects of epinephrine in dogs].
    Mouillé P
    C R Seances Soc Biol Fil; 1971; 165(6):1275-7. PubMed ID: 4262028
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympathomimetic effects of dichloroisoproterenol.
    Vogin EE; Rice AJ; Dhalla NS
    Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):300-10. PubMed ID: 4378835
    [No Abstract]   [Full Text] [Related]  

  • 8. [Physiological basis of ACh-induced atrial fibrillation by the selective administration into the sinus node artery of the dog-interaction of ACh-catecholamines].
    Chiba S
    Nihon Yakurigaku Zasshi; 1968 Nov; 64(6):657-67. PubMed ID: 4387747
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of carotid sinus reflex, cardiac distention and catecholamines in the vagal escape mechanism.
    Peiss CN; Priola DV; Spurgeon HA
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):347-58. PubMed ID: 4155281
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).
    Aramendía P; Kaumann AJ
    J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular effects of prostaglandin E1.
    Nakano J; McCurdy JR
    J Pharmacol Exp Ther; 1967 Jun; 156(3):538-47. PubMed ID: 6028880
    [No Abstract]   [Full Text] [Related]  

  • 12. The cardiovascular activity of 2-amino-5-(3,4-dichlorophenoxymethyl)-2-oxazoline (APMO).
    Abdallah AH; White HD
    Toxicol Appl Pharmacol; 1973 Dec; 26(4):513-22. PubMed ID: 4149198
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacologic inhibition of the mobilization of free fatty acids].
    Bert F; Paoletti R
    Rev Atheroscler (Paris); 1968; 10(1):31-42. PubMed ID: 4386492
    [No Abstract]   [Full Text] [Related]  

  • 14. Interactions of sympathomimetic and sympatholytic agents in normotensive and hypertensive subjects.
    Kato M; Komata KE
    Tohoku J Exp Med; 1969 Mar; 97(3):213-31. PubMed ID: 5789718
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular and lipid mobilizing effects of tetrahydroisoquinoline.
    Tóth E; Fassina G; Soncin ES
    Arch Int Pharmacodyn Ther; 1967 Oct; 169(2):375-83. PubMed ID: 6064567
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenergic mechanisms in the initiation of cardiac arrhythmias.
    Garvey HL
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):376-90. PubMed ID: 4391896
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular actions of a new metabolite of propranolol: isopropylamine.
    Ishizaki T; Privitera PJ; Walle T; Gaffney TE
    J Pharmacol Exp Ther; 1974 Jun; 189(3):626-32. PubMed ID: 4152314
    [No Abstract]   [Full Text] [Related]  

  • 18. Sympathetic beta adrenergic vasodilatation in skeletal muscle of the dog.
    Viveros OH; Garlick DG; Renkin EM
    Am J Physiol; 1968 Nov; 215(5):1218-25. PubMed ID: 5723290
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical vagal tachycardia in ganglion-blocked anesthetized dogs.
    Antonaccio MJ
    Eur J Pharmacol; 1974 Sep; 28(1):59-65. PubMed ID: 4154205
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of adrenergic agonists and antagonists on potassium metabolism.
    Lockwood RH; Lum BK
    J Pharmacol Exp Ther; 1974 Apr; 189(1):119-29. PubMed ID: 4823287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.